Molecular characterization of the diabetes-associated mouse MHC class II protein, I-A(g7)

International Immunology

Volumn 9, Issue 1, 1997, Pages 43-51

  Reizis, Boris ^a   Eisenstein, Miriam ^a   Bočková, Jana ^a   Könen Waisman, Stephanie ^a   Mor, Felix ^a   Elias, Dana ^a   Cohen, Irun R ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Autoimmunity; Non obese diabetic mice; Peptides

Indexed keywords

AMINO ACID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SERINE;

ALLELE; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIMERIZATION; DISEASE PREDISPOSITION; HAPLOTYPE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING;

AMINO ACID SEQUENCE; ANIMALS; DIABETES MELLITUS, TYPE 1; HISTOCOMPATIBILITY ANTIGENS CLASS II; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED NOD; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN BINDING; PROTEIN CONFORMATION;

EID: 0031040913     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/9.1.43     Document Type: Article

References (36)

1. Kikutani, H. and Makino, S. 1992. The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51:285.
2. Bach, J. F. 1995. Insulin-dependent diabetes mellitus as a β-cell targeted disease of immunoregulation. J. Autoimmun. 8:439.
3. Wicker, L. S., Todd, J. A. and Peterson, L. B. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:179.
4. Acha-Orbea, H. and McDevitt, H. O. 1987. The first external domain of the nonobese diabetic mouse class II I-A β chain is unique. Proc. Natl Acad. Sci. USA 84:2435.
5. Steinman, L. 1995. Escape from 'Horror Autotoxicus': pathogenesis and treatment of autoimmune disease. Cell 80:7.
6. Thorsby, E. 1995. HLA-associated disease susceptibility - which genes are primarily involved? The Immunologist 3:51.
7. Reich, E.-P., von Grafenstein, H., Barlow, A., Swenson, K. E., Williams, K. and Janeway, C. A., Jr. 1994. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice. J. Immunol. 152:2279.
8. Rammensee, H.-G., Friede, T. and Stefanoviç, S. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41:178.
9. g7 molecules from non-obese diabetic mice are poor peptide binders. J. Immunol. 156:450.
10. Rammensee, H.-G. 1995. Chemistry of peptides associated with MHC class I and class II molecules. Curr. Opin. Immunol. 7:85.
11. I. Int. Immunol., in press.
12. Buus, S., Sette, A., Colon, S. M., Miles, C. and Grey, H. M. 1987. The relation between major histocompatibility complex (MHC) restriction and the capacity of la to bind immunogenic peptides. Science 235:1353.
13. Könen-Waisman, S., Fridkin, M. and Cohen, I. R. 1995. Self and foreign 60-kilodalton heat shock protein T cell epitope peptides serve as immunogenic carriers for a T cell-independent sugar antigen. J. Immunol. 154:5977.
14. Germain, R. N. and Rinker, A. G., Jr. 1993. Peptide binding inhibits protein aggregation of invariant chain-free class II dimers and promotes surface expression of occupied molecules. Nature 363:725.
15. McMaster, W. R. and Williams, A. F. 1979. Identification of la glycoproteins in rat thymus and purification from rat spleen. Eur. J. Immunol. 9:426.
16. Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J. L. and Wiley, D. C. 1993. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33.
17. Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L. and Wiley, D. C. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215.
18. Levitt, M. 1983. Molecular dynamics of native protein I. Computer simulation of trajectories. J. Mol. Biol. 168:595.
19. Germain, R. N. and Margulies, D. H. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403.
20. Kaufmann, D. L., Clare-Salzler, M., Tian, J., Forsthuber, T., Ting, G. S. P., Robinson, P., Atkinson, M. A., Sercarz, E. E., Tobin, A. J. and Lehmann, P. V. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69.
21. Busch, R. and Mellins, E. 1996. Developing and shedding inhibitions: how MHC class II molecules reach maturity. Curr. Opin. Immunol. 8:51.
22. Vaysburd, M., Lock, C. and McDevitt, H. O. 1995. Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides. J. Exp. Med. 182:897.
23. Elias, D., Reshef, T., Birk, O. S., van der Zee, R., Walker, M. D. and Cohen, I. R. 1991. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65 kDa heat shock protein. Proc. Natl Acad. Sci. USA 88:3088.
24. Quinn, A. and Sercarz, E. 1995. Analysis and modulation of the anti-GAD response in the NOD mouse In: Immunology of Diabetes '95. Abstracts. Autoimmunity 21:25.
25. Daniel, D., Gill, R. G., Schloot, N. and Wegmann, D. 1995. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25:1056.
26. Deng, H., Apple, R., Clare-Salzler, M., Trembleau, S., Mathis, D., Adorini, L. and Sercarz, E. 1993. Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune diseases. J. Exp. Med. 178:1675.
27. g7) mice share an amino acid motif. J. Immunol. 156:3000.
28. Reske, K. and Weitzel, R. 1985. Immunologically discrete conformation isomers of I-A locus-equivalent class II molecules detected in Lewis rats Eur. J. Immunol. 15:1229.
29. Schafer, P. H. and Pierce, S. K. 1994. Evidence for dimers of MHC class II molecules in B lymphocytes and their role in low affinity T cell responses. Immunity 1:699.
30. Lanzavecchia, A., Reid, P. A. and Watts, C. 1992. Irreversible association of peptides with class II MHC molecules in living cells. Nature 357:249.
31. Nelson, C. A., Petzold, S. J. and Unanue, E. R. 1993. Identification of two distinct properties of class II major histocompatibility complex-associated peptides. Proc. Natl Acad. Sci. USA 90:1227.
32. Nelson, C. A., Petzold, S. J. and Unanue, E. R. 1994. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 371:250.
33. Germain, R. N. and Hendrix, L. R. 1991. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134.
34. Johansen, B. H., Vartdal, F., Eriksen, J. A., Thorsby, E. and Sollid, L. M. 1996. Identification of a putative motif for binding of peptides to HLA-DQ2. Int. Immunol. 8:177.
35. Kwok, W. W., Domeier, M. E., Raymond, F. C., Byers, P. and Nepom, G. T. 1996. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J. Immunol. 156:2171.
36. Hammer, J., Gallazzi, F., Bono, E., Karr, R. W., Guenot, J., Valsasnini, P., Nagy, Z. A. and Sinigaglia, F. 1995. Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis. J. Exp. Med. 181:1847.